検眼鏡の世界市場：展望と予測 (2022年～2027年)

世界の眼科鏡の市場規模は、2022年から2027年に5.69%のCAGRで成長すると予測されています。市場の主な促進要因として、先進国におえるアイケア (眼病治療) サービスへの意識向上や、眼病の有病率の上昇や手術件数の増加、眼病治療に対する政府の支援拡大などが挙げられます。また、技術進歩の成果 (レーザー式間接眼底カメラ、スマートフォン用間接眼底カメラ、ビジョンブースト技術など) や最先端製品の登場などが市場を大きく変化させています。

種類別では、直接検眼鏡が2021年に世界市場の60.16%を占めています。適応症別では、緑内障が31.81%を占め、次いで糖尿病性網膜症が23.37%、加齢性黄斑変性症が18.03%、網膜剥離が5.27%となっています。エンドユーザー別では、眼科医院・病院が52.34%の市場シェアを獲得しています。

地域別の市場シェアを見てみると、北米が2021年に世界市場の38.82%のシェアを占め、次いで欧州が32.89%、アジア太平洋が20.23%、ラテンアメリカが5.04%、中東・アフリカが3.01%となっています。

当レポートでは、世界の検眼鏡の市場について分析し、製品の概略や市場の基本構造、主な市場促進・抑制要因、全体的な市場規模の動向見通し、種類別・適応症別・エンドユーザー別および地域別の詳細動向、主要企業のプロファイルなどを調査しております。

目次

第1章 分析手法

第2章 分析目的

第3章 分析プロセス

第4章 分析範囲

第5章 分析の前提条件と警告

第6章 市場概略

第7章 イントロダクション

第8章 市場の機会と動向

• 検眼鏡の技術進歩と新たな用途
• 政府の眼病治療のイニシアチブ
• 新興国における成長機会の拡大

第9章 市場成長の実現要因

• 先進国におけるアイケアサービスの知名度の上昇
• 眼病の有病率と外科的処置の増加
• 高度な検眼鏡の進歩
• 眼病患者の人口増加

第10章 市場の課題

• 新興市場におけるアイケアサービスの欠如
• 発展途上国における眼科医の不足
• 厳格な規制と製品のリコール

第11章 市場情勢

• 市場概要
• 市場規模とその予測
• ファイブフォース分析

第12章 種類

• 市場のスナップショットと成長エンジン
• 市場概要
• 直接検眼鏡
  • 市場概要
  • 市場規模とその予測
  • 地域別分析
• 間接検眼鏡

第13章 適応症

• 市場のスナップショットと成長エンジン
• 市場概要
• 緑内障
• 糖尿病性網膜症
• 加齢性黄斑変性症
• 網膜剥離
• その他

第14章 エンドユーザー

• 市場のスナップショットと成長エンジン
• 市場概要
• 眼科医院・病院
• 眼科医・検眼医
• 外来手術センター

第15章 地域

• 市場のスナップショットと成長エンジン
• 各地域の概要

第16章 北米

• 市場概要
• 市場規模とその予測
• 種類別
  • 市場規模とその予測
• 適応症別
• エンドユーザー別
• 主要国
  • 米国：市場規模とその予測
  • カナダ：市場規模とその予測

第17章 欧州

• 市場概要
• 市場規模とその予測
• 種類別
• 適応症別
• エンドユーザー別
• 主要国
  • ドイツ：市場規模とその予測
  • フランス：市場規模とその予測
  • 英国：市場規模とその予測
  • イタリア：市場規模とその予測
  • スペイン：市場規模とその予測

第18章 アジア太平洋

• 市場概要
• 市場規模とその予測
• 種類別
• 適応症別
• エンドユーザー別
• 主要国
  • 日本：市場規模とその予測
  • 中国：市場規模とその予測
  • インド：市場規模とその予測
  • オーストラリア：市場規模とその予測
  • 韓国：市場規模とその予測

第19章 ラテンアメリカ

• 市場概要
• 市場規模とその予測
• 種類別
• 適応症別
• エンドユーザー別
• 主要国
  • ブラジル：市場規模とその予測
  • メキシコ：市場規模とその予測
  • アルゼンチン：市場規模とその予測

第20章 中東・アフリカ

• 市場概要
• 市場規模とその予測
• 種類別
• 適応症別
• エンドユーザー別
• 主要国
  • トルコ：市場規模とその予測
  • 南アフリカ：市場規模とその予測
  • サウジアラビア：市場規模とその予測

第21章 競合情勢

• 競合の概要
• 市場シェア分析

第22章 主要企業のプロファイル

• HEINE
  • 事業概要
  • 主要製品
  • 主要戦略
  • 主な強み
  • 主な機会
• DINO-LITE EUROPE (ANMO ELECTRONICS CORPORATION)
• IRIDEX
• HALMA
• NIDEK
• OSCAR BOSCAROL
• RUDOLF RIESTER
• WELCH ALLYN (HILL ROM)

第23章 その他のベンダー

• ALBERT WAESCHLE
  • 事業の概要
  • 主要製品
• AMERICAN DIAGNOSTIC CORPORATION
• SHANGHAI BOLAN OPTICAL ELECTRIC
• CARL ZEISS
• LUMIBIRD GROUP (ELLEX)
• ESSILOR INTERNATIONAL (ESSILOR INSTRUMENTS USA)
• HEIDELBERG ENGINEERING
• INVOTECH EXCEL
• MEDLINE INDUSTRIES
• NEITZ INSTRUMENTS
• SUZHOU KANGJIE MEDICAL
• SPENGLER HOLTEX GROUP
• TOPCON
• LUMENIS
• ZUMAX MEDICAL CO. LTD
• 66 VISION TECH
• ZHEJIANG HONSUN MEDICAL TECHNOLOGIES CO. LTD

第24章 分析概要

• 重要なポイント
• 戦略提言

第25章 定量的サマリー

第26章 付録

LIST OF EXHIBITS

• EXHIBIT 1 GLOBAL OPHTHALMOSCOPE MARKET: SEGMENTATION
• EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
• EXHIBIT 3 GLOBAL EYE HEALTH 2020
• EXHIBIT 4 IMPACT OF TECHNOLOGICAL ADVANCES & NEW APPLICATIONS OF OPHTHALMOSCOPES
• EXHIBIT 5 TECHNOLOGICAL ADVANCES IN OPHTHALMOSCOPES
• EXHIBIT 6 IMPACT OF GOVERNMENT'S EYE CARE INITIATIVES
• EXHIBIT 7 IMPACT OF HIGHER GROWTH OPPORTUNITIES IN EMERGING MARKETS
• EXHIBIT 8 EMERGING MARKETS & HEALTHCARE & EYE CARE DEVELOPMENT WITH EXPENDITURE (2019)
• EXHIBIT 9 IMPACT OF RISE IN AWARENESS OF EYE CARE SERVICES IN DEVELOPED COUNTRIES
• EXHIBIT 10 IMPACT OF RISE IN EYE DISORDER PREVALENCE & SURGICAL PROCEDURES
• EXHIBIT 11 MAJOR EYE DISEASES THAT REQUIRE OPHTHALMOSCOPES FOR EXAMINATIONS
• EXHIBIT 12 DIABETIC RETINOPATHY PREVALENCE BY REGION 2021
• EXHIBIT 13 IMPACT OF ADVENT OF ADVANCED OPHTHALMOSCOPES
• EXHIBIT 14 IMPACT OF INCREASE IN PATIENT POPULATION WITH EYE DISORDERS
• EXHIBIT 15 GLOBAL KEY FACTS ABOUT BLINDNESS & VISION IMPAIRMENT
• EXHIBIT 16 EYE DISORDERS WITH AN ESTIMATED PREVALENCE
• EXHIBIT 17 IMPACT OF LACK OF EYE CARE SERVICES IN EMERGING MARKETS
• EXHIBIT 18 IMPACT OF INSUFFICIENT OPHTHALMOLOGISTS IN DEVELOPING COUNTRIES
• EXHIBIT 19 OPHTHALMOLOGISTS IN LOWER-MIDDLE-INCOME COUNTRIES
• EXHIBIT 20 IMPACT OF STRINGENT REGULATIONS & PRODUCT RECALLS
• EXHIBIT 21 GLOBAL OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 22 GLOBAL OPHTHALMOSCOPE MARKET SHARE BY GEOGRAPHY 2021-2027 (%)
• EXHIBIT 23 GLOBAL OPHTHALMOSCOPE MARKET BY TYPE 2021-2027 (% SHARE)
• EXHIBIT 24 GLOBAL OPHTHALMOSCOPE MARKET BY INDICATION 2021-2027 (% SHARE)
• EXHIBIT 25 GLOBAL OPHTHALMOSCOPE MARKET BY END-USER 2021-2027 (% SHARE)
• EXHIBIT 26 FIVE FORCES ANALYSIS 2021
• EXHIBIT 27 INCREMENTAL GROWTH BY TYPE 2021 & 2027
• EXHIBIT 28 GLOBAL OPHTHALMOSCOPE MARKET BY TYPE 2022-2027
• EXHIBIT 29 GLOBAL OPHTHALMOSCOPE MARKET BY TYPE: INCREMENTAL GROWTH
• EXHIBIT 30 GLOBAL OPHTHALMOSCOPE MARKET BY TYPE: ABSOLUTE GROWTH
• EXHIBIT 31 RETINAL DISEASES THAT REQUIRE OPHTHALMOSCOPES & EYE EXAMINATIONS
• EXHIBIT 32 GLOBAL OPHTHALMOSCOPE MARKET BY DIRECT OPHTHALMOSCOPE: INCREMENTAL GROWTH &ABSOLUTE GROWTH
• EXHIBIT 33 GLOBAL OPHTHALMOSCOPE MARKET BY DIRECT OPHTHALMOSCOPE 2021-2027 ($ MILLION)
• EXHIBIT 34 LATTICE DEGENERATION PREVALENCE WITH EYE CONDITIONS 2021
• EXHIBIT 35 GLOBAL OPHTHALMOSCOPE MARKET BY INDIRECT OPHTHALMOSCOPE: INCREMENTAL GROWTH &ABSOLUTE GROWTH
• EXHIBIT 36 GLOBAL OPHTHALMOSCOPE MARKET BY INDIRECT OPHTHALMOSCOPE 2021-2027 ($ MILLION)
• EXHIBIT 37 INCREMENTAL GROWTH BY SEGMENT 2021 & 2027
• EXHIBIT 38 GLOBAL OPHTHALMOSCOPE MARKET BY INDICATION 2022-2027
• EXHIBIT 39 GLOBAL OPHTHALMOSCOPE MARKET BY INDICATION: INCREMENTAL GROWTH
• EXHIBIT 40 GLOBAL OPHTHALMOSCOPE MARKET BY INDICATION: ABSOLUTE GROWTH
• EXHIBIT 41 GLOBAL GLAUCOMA PREVALENCE BY WHO
• EXHIBIT 42 GLOBAL PREVALENCE OF PROGRESSIVE OPEN-ANGLE GLAUCOMA 2021
• EXHIBIT 43 GLOBAL PROJECTED GLAUCOMA PREVALENCE BY 2040 (MILLION)
• EXHIBIT 44 GLOBAL OPHTHALMOSCOPE MARKET BY GLAUCOMA: INCREMENTAL GROWTH &ABSOLUTE GROWTH
• EXHIBIT 45 GLOBAL OPHTHALMOSCOPE MARKET BY GLAUCOMA 2021-2027 ($ MILLION)
• EXHIBIT 46 GLOBAL DIABETIC RETINOPATHY PREVALENCE 2021 (MILLION)
• EXHIBIT 47 DIABETIC RETINOPATHY PREVALENCE BY REGION 2021
• EXHIBIT 48 GLOBAL OPHTHALMOSCOPE MARKET BY DIABETIC RETINOPATHY: INCREMENTAL GROWTH &ABSOLUTE GROWTH
• EXHIBIT 49 GLOBAL OPHTHALMOSCOPE MARKET BY DIABETIC RETINOPATHY 2021-2027 ($ MILLION)
• EXHIBIT 50 GLOBAL OPHTHALMOSCOPE MARKET BY AGE-RELATED MACULAR DEGENERATION 2021-2027 ($ MILLION)
• EXHIBIT 51 GLOBAL OPHTHALMOSCOPE MARKET BY AGE-RELATED MACULAR DEGENERATION: INCREMENTAL GROWTH &ABSOLUTE GROWTH
• EXHIBIT 52 GLOBAL OPHTHALMOSCOPE MARKET BY RETINAL DETACHMENT: INCREMENTAL GROWTH &ABSOLUTE GROWTH
• EXHIBIT 53 GLOBAL OPHTHALMOSCOPE MARKET BY RETINAL DETACHMENT 2021-2027 ($ MILLION)
• EXHIBIT 54 OTHER EYE DISEASES DIAGNOSED USING OPHTHALMOSCOPES
• EXHIBIT 55 GLOBAL OPHTHALMOSCOPE MARKET BY OTHERS: INCREMENTAL GROWTH &ABSOLUTE GROWTH
• EXHIBIT 56 GLOBAL OPHTHALMOSCOPE MARKET BY OTHERS 2021-2027 ($ MILLION)
• EXHIBIT 57 INCREMENTAL GROWTH BY END-USER 2021 & 2027
• EXHIBIT 58 GLOBAL OPHTHALMOSCOPE MARKET BY END-USER 2022-2027
• EXHIBIT 59 GLOBAL OPHTHALMOSCOPE MARKET BY END-USER: INCREMENTAL GROWTH
• EXHIBIT 60 GLOBAL OPHTHALMOSCOPE MARKET BY END-USER: ABSOLUTE GROWTH
• EXHIBIT 61 GLOBAL OPHTHALMOSCOPE MARKET BY EYE CLINICS & HOSPITALS: INCREMENTAL GROWTH &ABSOLUTE GROWTH
• EXHIBIT 62 GLOBAL OPHTHALMOSCOPE MARKET BY EYE CLINICS & HOSPITALS 2021-2027 ($ MILLION)
• EXHIBIT 63 TOTAL NUMBER OF GLOBAL OPHTHALMOLOGISTS IN 2015
• EXHIBIT 64 GLOBAL OPHTHALMOSCOPE MARKET BY OPHTHALMOLOGISTS & OPTOMETRISTS: INCREMENTAL GROWTH &ABSOLUTE GROWTH
• EXHIBIT 65 GLOBAL OPHTHALMOSCOPE MARKET BY OPHTHALMOLOGISTS & OPTOMETRISTS 2021-2027 ($ MILLION)
• EXHIBIT 66 REASON FOR HIGH DEMAND FOR ACSS IN THE EYE CARE SECTOR
• EXHIBIT 67 GLOBAL OPHTHALMOSCOPE MARKET BY AMBULATORY SURGICAL CENTERS: INCREMENTAL GROWTH &ABSOLUTE GROWTH
• EXHIBIT 68 GLOBAL OPHTHALMOSCOPE MARKET BY AMBULATORY SURGICAL CENTERS 2021-2027 ($ MILLION)
• EXHIBIT 69 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 70 GLOBAL OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2022-2027
• EXHIBIT 71 GLOBAL OPHTHALMOSCOPE MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
• EXHIBIT 72 GLOBAL OPHTHALMOSCOPE MARKET BY GEOGRAPHY INCREMENTAL GROWTH
• EXHIBIT 73 NORTH AMERICA OPHTHALMOSCOPE MARKET: INCREMENTAL GROWTH &ABSOLUTE GROWTH
• EXHIBIT 74 NORTH AMERICA OPHTHALMOSCOPE MARKET: KEY COUNTRIES 2021 ($ MILLION)
• EXHIBIT 75 OPHTHALMOSCOPE MARKET IN NORTH AMERICA 2021-2027 ($ MILLION)
• EXHIBIT 76 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
• EXHIBIT 77 EYE DISORDERS PREVALENCE IN US 2015-2020
• EXHIBIT 78 EYE DISEASE PREVALENCE IN THE US
• EXHIBIT 79 US OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 80 CANADA: EYE CONDITIONS AND PREVALENCE RATE
• EXHIBIT 81 CANADA OPHTHALMOSCOPE MARKET 2022-2027 ($ MILLION)
• EXHIBIT 82 EUROPE: PREVALENCE OF EYE DISEASES
• EXHIBIT 83 OPHTHALMOSCOPE MARKET EUROPE: INCREMENTAL GROWTH &ABSOLUTE GROWTH
• EXHIBIT 84 EUROPE OPHTHALMOSCOPE MARKET: KEY COUNTRIES 2021 ($ MILLION)
• EXHIBIT 85 OPHTHALMOSCOPE MARKET IN EUROPE 2021-2027 ($ MILLION)
• EXHIBIT 86 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
• EXHIBIT 87 GERMANY OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 88 FRANCE OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 89 PRIMARY OPEN-ANGLE GLAUCOMA PREVALENCE IN THE UK BY AGE (40 YEARS, 60 YEARS, AND 80 YEARS)
• EXHIBIT 90 UK OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 91 ITALY: EYE DISEASE PREVALENCE IN PEOPLE AGED 50 YEARS AND OVER
• EXHIBIT 92 ITALY OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 93 NORTHERN SPAIN: DIABETIC RETINOPATHY PREVALENCE 2020
• EXHIBIT 94 SPAIN OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 95 APAC EYE DISEASE PREVALENCE
• EXHIBIT 96 POPULATION WITH MODERATE-TO-SEVERE VISUAL IMPAIRMENT IN APAC 2019 (MILLION)
• EXHIBIT 97 OPHTHALMOSCOPE MARKET APAC: INCREMENTAL GROWTH &ABSOLUTE GROWTH
• EXHIBIT 98 APAC OPHTHALMOSCOPE MARKET: KEY COUNTRIES 2021 ($ MILLION)
• EXHIBIT 99 OPHTHALMOSCOPE MARKET IN APAC 2021-2027 ($ MILLION)
• EXHIBIT 100 INCREMENTAL GROWTH IN APAC 2021 & 2027
• EXHIBIT 101 VISUAL IMPAIRMENT CAUSING DISEASES 2021 (% SHARE)
• EXHIBIT 102 JAPAN OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 103 CHINA OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 104 INDIA OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 105 AUSTRALIA OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 106 SOUTH KOREA OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 107 OPHTHALMOSCOPE MARKET IN LATIN AMERICA: INCREMENTAL GROWTH &ABSOLUTE GROWTH
• EXHIBIT 108 OPHTHALMOSCOPE MARKET IN LATIN AMERICA: KEY COUNTRIES 2021 ($ MILLION)
• EXHIBIT 109 OPHTHALMOSCOPE MARKET IN LATIN AMERICA 2021-2027 ($ MILLION)
• EXHIBIT 110 INCREMENTAL GROWTH IN APAC 2021 & 2027
• EXHIBIT 111 BRAZIL OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 112 MEXICO OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 113 PREVALENCE OF EYE DISEASES & RELATIVE PERCENTAGE OF FIVE PRINCIPAL DIAGNOSIS 2014-2017
• EXHIBIT 114 ARGENTINA OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 115 OPHTHALMOSCOPE MARKET IN THE MIDDLE EAST & AFRICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
• EXHIBIT 116 OPHTHALMOSCOPE MARKET IN MIDDLE EAST & AFRICA: KEY COUNTRIES 2021 ($ MILLION)
• EXHIBIT 117 OPHTHALMOSCOPE MARKET IN THE MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
• EXHIBIT 118 INCREMENTAL GROWTH IN THE MIDDLE EAST & AFRICA 2021 & 2027
• EXHIBIT 119 CRUDE PREVALENCE OF VISION LOSS IN TURKEY IN 2020 (%)
• EXHIBIT 120 TURKEY: ADULT POPULATION WITH EYE DISEASES (%)
• EXHIBIT 121 TURKEY OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 122 SOUTH AFRICA OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 123 PREVALENCE OF VISUAL IMPAIRMENT-CAUSING DISEASES 2020
• EXHIBIT 124 SAUDI ARABIA OPHTHALMOSCOPE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 125 IRIDEX ANNUAL REVENUE 2017-2020 ($ MILLION)
• EXHIBIT 126 HALMA ANNUAL REVENUE 2019-2021 ($ MILLION)
• EXHIBIT 127 NIDEK: ANNUAL REPORT 2018-2020 ($ MILLION)
• EXHIBIT 128 NIDEK: BUSINESS SEGMENT ANNUAL REVENUE 2020 ($ MILLION)
• EXHIBIT 129 NIDEK: ANNUAL REVENUE BY GEOGRAPHY 2020 (% SHARE)

LIST OF TABLES

• TABLE 1 KEY CAVEATS
• TABLE 2 CURRENCY CONVERSION 2015-2021
• TABLE 3 GLOBAL DIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 4 GLOBAL DIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 5 GLOBAL INDIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 6 GLOBAL INDIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (% SHARE)
• TABLE 7 GLAUCOMA OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 8 GLAUCOMA OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 9 DIABETIC RETINOPATHY OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 10 DIABETIC RETINOPATHY OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 11 AGE-RELATED MACULAR DEGENERATION OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 12 AGE-RELATED MACULAR DEGENERATION OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 13 RETINAL DETACHMENT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 14 RETINAL DETACHMENT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 15 OTHERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 16 OTHERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 17 EYE CLINICS & HOSPITALS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 18 EYE CLINICS & HOSPITALS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 19 GLOBAL OPHTHALMOLOGISTS & OPTOMETRISTS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 20 GLOBAL OPHTHALMOLOGISTS & OPTOMETRISTS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 21 GLOBAL AMBULATORY SURGICAL CENTERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 22 GLOBAL AMBULATORY SURGICAL CENTERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 23 OPHTHALMOSCOPE MARKET BY TYPE IN NORTH AMERICA 2021-2027 ($ MILLION)
• TABLE 24 OPHTHALMOSCOPE MARKET BY TYPE IN NORTH AMERICA 2021-2027 (%)
• TABLE 25 OPHTHALMOSCOPE MARKET BY INDICATION IN NORTH AMERICA 2021-2027 ($ MILLION)
• TABLE 26 OPHTHALMOSCOPE MARKET BY INDICATION IN NORTH AMERICA 2021-2027 (%)
• TABLE 27 OPHTHALMOSCOPE MARKET BY END-USER IN NORTH AMERICA 2021-2027 ($ MILLION)
• TABLE 28 OPHTHALMOSCOPE MARKET BY END-USER IN NORTH AMERICA 2021-2027 (%)
• TABLE 29 OPHTHALMOSCOPE MARKET BY TYPE IN EUROPE 2021-2027 ($ MILLION)
• TABLE 30 OPHTHALMOSCOPE MARKET BY TYPE IN EUROPE 2021-2027 (%)
• TABLE 31 OPHTHALMOSCOPE MARKET BY INDICATION IN EUROPE 2021-2027 ($ MILLION)
• TABLE 32 OPHTHALMOSCOPE MARKET BY INDICATION IN EUROPE 2021-2027 (%)
• TABLE 33 OPHTHALMOSCOPE MARKET BY END-USER IN EUROPE 2021-2027 ($ MILLION)
• TABLE 34 OPHTHALMOSCOPE MARKET BY END-USER IN EUROPE 2021-2027 (%)
• TABLE 35 OPHTHALMOSCOPE MARKET BY TYPE IN APAC 2021-2027 ($ MILLION)
• TABLE 36 OPHTHALMOSCOPE MARKET BY TYPE IN APAC 2021-2027 (%)
• TABLE 37 OPHTHALMOSCOPE MARKET BY INDICATION IN APAC 2021-2027 ($ MILLION)
• TABLE 38 OPHTHALMOSCOPE MARKET BY INDICATION IN APAC 2021-2027 (%)
• TABLE 39 OPHTHALMOSCOPE MARKET BY END-USER IN APAC 2021-2027 ($ MILLION)
• TABLE 40 OPHTHALMOSCOPE MARKET BY END-USER IN APAC 2021-2027 (%)
• TABLE 41 OPHTHALMOSCOPE MARKET BY TYPE IN LATIN AMERICA 2021-2027 ($ MILLION)
• TABLE 42 OPHTHALMOSCOPE MARKET BY TYPE IN LATIN AMERICA 2021-2027 (%)
• TABLE 43 OPHTHALMOSCOPE MARKET BY INDICATION IN LATIN AMERICA 2021-2027 ($ MILLION)
• TABLE 44 OPHTHALMOSCOPE MARKET BY INDICATION IN LATIN AMERICA 2021-2027 (%)
• TABLE 45 OPHTHALMOSCOPE MARKET BY END-USER IN LATIN AMERICA 2021-2027 ($ MILLION)
• TABLE 46 OPHTHALMOSCOPE MARKET BY END-USER IN LATIN AMERICA 2021-2027 (%)
• TABLE 47 OPHTHALMOSCOPE MARKET BY TYPE IN THE MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
• TABLE 48 OPHTHALMOSCOPE MARKET BY TYPE IN THE MIDDLE EAST & AFRICA 2021-2027 (%)
• TABLE 49 OPHTHALMOSCOPE MARKET BY INDICATION IN THE MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
• TABLE 50 OPHTHALMOSCOPE MARKET BY INDICATION IN THE MIDDLE EAST & AFRICA 2021-2027 (%)
• TABLE 51 OPHTHALMOSCOPE MARKET BY END-USER IN THE MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
• TABLE 52 OPHTHALMOSCOPE MARKET BY END-USER IN THE MIDDLE EAST & AFRICA 2021-2027 (%)
• TABLE 53 HEINE OPTOTECHNIK: MAJOR PRODUCT OFFERINGS
• TABLE 54 DINO-LITE EUROPE: MAJOR PRODUCT OFFERINGS
• TABLE 55 IRIDEX: MAJOR PRODUCT OFFERINGS
• TABLE 56 HALMA: MAJOR PRODUCT OFFERINGS
• TABLE 57 NIDEK: MAJOR PRODUCT OFFERINGS
• TABLE 58 OSCAR BOSCAROL: MAJOR PRODUCT OFFERINGS
• TABLE 59 RUDOLF RIESTER: MAJOR PRODUCT OFFERINGS
• TABLE 60 WELCH ALLYN: MAJOR PRODUCT OFFERINGS
• TABLE 61 ALBERT WAESCHLE: MAJOR PRODUCT OFFERINGS
• TABLE 62 AMERICAN DIAGNOSTIC CORPORATION: MAJOR PRODUCT OFFERINGS
• TABLE 63 SHANGHAI BOLAN OPTICAL ELECTRIC: MAJOR PRODUCT OFFERINGS
• TABLE 64 CARL ZEISS: MAJOR PRODUCT OFFERINGS
• TABLE 65 ELLEX: MAJOR PRODUCT OFFERINGS
• TABLE 66 ESSILOR INTERNATIONAL (ESSILOR INSTRUMENTS USA): MAJOR PRODUCT OFFERINGS
• TABLE 67 HEIDELBERG ENGINEERING: MAJOR PRODUCT OFFERINGS
• TABLE 68 INVOTECH EXCEL: MAJOR PRODUCT OFFERINGS
• TABLE 69 MEDLINE INDUSTRIES: MAJOR PRODUCT OFFERINGS
• TABLE 70 NEITZ INSTRUMENTS: MAJOR PRODUCT OFFERINGS
• TABLE 71 SUZHOU KANGJIE MEDICAL INC: MAJOR PRODUCT OFFERINGS
• TABLE 72 SPENGLER HOLTEX GROUP: MAJOR PRODUCT OFFERINGS
• TABLE 73 TOPCON: MAJOR PRODUCT OFFERINGS
• TABLE 74 LUMENIS: MAJOR PRODUCT OFFERINGS
• TABLE 75 ZUMAX MEDICAL CO. LTD.: MAJOR PRODUCT OFFERINGS
• TABLE 76 66 VISION TECH: MAJOR PRODUCT OFFERINGS
• TABLE 77 ZHEJIANG HONSUN MEDICAL TECHNOLOGIES CO. LTD: MAJOR PRODUCT OFFERINGS
• TABLE 78 GLOBAL OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 79 GLOBAL OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 80 GLOBAL OPHTHALMOSCOPE MARKET BY TYPE 2021-2027 ($ MILLION)
• TABLE 81 GLOBAL OPHTHALMOSCOPE MARKET BY TYPE 2021-2027 (%)
• TABLE 82 GLOBAL OPHTHALMOSCOPE MARKET BY INDICATION 2021-2027 ($ MILLION)
• TABLE 83 GLOBAL OPHTHALMOSCOPE MARKET BY INDICATION 2021-2027 (%)
• TABLE 84 GLOBAL OPHTHALMOSCOPE MARKET BY END-USER 2021-2027 ($ MILLION)
• TABLE 85 GLOBAL OPHTHALMOSCOPE MARKET BY END-USER 2021-2027 (%)
• TABLE 86 GLOBAL DIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 87 GLOBAL DIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 88 GLOBAL INDIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 89 GLOBAL INDIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 90 GLOBAL GLAUCOMA OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 91 GLOBAL GLAUCOMA OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 92 GLOBAL DIABETIC RETINOPATHY OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 93 GLOBAL DIABETIC RETINOPATHY OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 94 GLOBAL AGE-RELATED MACULAR DEGENERATION OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 95 GLOBAL AGE-RELATED MACULAR DEGENERATION OPHTHALMOSCOPE BY GEOGRAPHY 2021-2027 (%)
• TABLE 96 GLOBAL RETINAL DETACHMENT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 97 GLOBAL RETINAL DETACHMENT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 98 GLOBAL OTHERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 99 GLOBAL OTHERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 100 GLOBAL EYE CLINICS & HOSPITALS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 101 GLOBAL EYE CLINICS & HOSPITALS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 102 GLOBAL OPHTHALMOLOGISTS & OPTOMETRISTS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 103 GLOBAL OPHTHALMOLOGISTS & OPTOMETRISTS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 104 GLOBAL AMBULATORY SURGICAL CENTERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 105 GLOBAL AMBULATORY SURGICAL CENTERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021-2027 (%)

The Global Ophthalmoscopes market is expected to grow at a CAGR of 5.69% during 2022-2027

The following factors are likely to contribute to the global ophthalmoscope market growth during the forecast period:

• Raising Awareness Among Patients Population by Increasing the Eye Care Services in Developed Countries
• Increasing Eye Disorders Prevalence & Surgical Procedures
• Surging Prevalence of Eye Disorders Patient Population
• Increasing Government Initiative for Eye Care

Ophthalmoscope (Fundoscopy) is a medical device used to perform ophthalmoscopy to understand the health of vitreous humor, optic disc, & retina of the eye. So, ophthalmoscopy is the most vital part of eye examination and is used to detect the symptoms of retinal vascular diseases such as cataracts, glaucoma, diabetic retinopathy, and age macular degeneration. It involves eye checkups for patients who suffer from diabetes mellitus conditions in which ophthalmoscopy plays a vital role in routinely monitoring the diabetic retinopathy condition.

The rising prevalence of eye diseases is driving the growth of the eye testing equipment market. Around 596 million people are suffering from distance vision impairment globally, of which 43 million people are blind. Approximately 510 million patients, on the other hand, had uncorrected near vision impairment. Most of these populations live in low-middle-income countries, accounting for 90% of cases. Around 895 million people will be suffering from distance vision impairment by 2050, and 61 million be blind. The increasing target population offers high growth opportunities to the players.

OPHTHALMOSCOPES MARKET TRENDS

Technological innovations and advanced products will further optimize the usage of ophthalmoscope devices in the industry. Scanning laser ophthalmoscopes have been available in the market since the 1990s, but recently increasing popularity and plenty of advantages delivery gives new direction to the industry. Currently, scanning laser ophthalmoscopes improved significantly. These ophthalmoscopes can obtain images with broader views of the ocular fundus with maintaining high resolution and increasing the application rate in eye examinations. These are superior in conventional fundoscopy with their ability to image abnormal alteration of choroid and retina.

On the other side, indirect laser ophthalmoscopy, smartphone base indirect ophthalmoscope, and vision boost technology are some innovations that are revolutionizing the industry. Also, the rising application of ophthalmoscopes in other medical fields such as neurology and headache treatment will create new opportunities in the upcoming time.

VENDOR ANALYSIS

• In 2021, Heine launched a new indirect ophthalmoscope with the product Omega600. By introducing new products, the company made a significant change in the market with vision boost technology to increase the illumination and increase the clinician's capability to test the patient's cataract condition and vitreous opacities.
• In 2021, the BMJ journal reported that the smartphone ophthalmoscopy technology has a potential way in the covid-19 era for non-ophthalmology medicine. Smartphone ophthalmoscope has generally accounted for more favorably than direct handling time. This device gives the practitioners the capacity of long-distance working to examine and view the fundus from around arm's length compared to the general Ophthalmoscope.
• In 2021, the Hillrom company introduced the Welch Allyn PanOptic Plus Ophthalmoscope devices that boast a 20X larger viewing area.

Key Players

• Heine USA Ltd
• Dino Lite Europe
• Iridex Corporation
• Halma
• Nidek Co. Ltd.
• Oscar Boscarol S.r.l
• Rudolf Riester GmbH
• US Ophthalmic

Other Prominent Vendors

• Albert Waeschle
• American Diagnostic Corporation
• Shanghai Bolan Optical Electric Co Ltd
• Carl Zeiss
• Ellex
• Essilor International (Essilor Instruments USA)
• Heidelberg Engineering
• Invotech Excel
• Medline Industries LP
• Neitz Instruments Co Ltd
• Suzhou Kangjie Medical Inc
• Spengler
• Topcon Co. Ltd
• Lumenis
• Zumax Medical
• 66 Vision Tech
• Zhejiang Honsun Medical Technologies Co. Ltd

MARKET DRIVERS

Manufacturers' enhanced efforts to promote awareness about developments in ophthalmoscope technology are driving the global ophthalmoscopes market expansion. Furthermore, rising healthcare expenditures for the treatment of vision loss, blindness, and sight-threatening disorders are predicted to boost demand for primary eye care and examinations, hence, increasing the demand for critical equipment such as ophthalmoscopes over the forecast period. On the other side increasing prevalence of eye diseases influence the need for eye examination and drives the high growth of ophthalmoscopes applications. Cataract, glaucoma, diabetic retinopathy, and age-related macular degeneration are the primary eye condition that requires ophthalmoscopes.

The increasing prevalence of the above conditions and excellent access to eye care services in developed countries positively triggered the application rate of ophthalmoscopes. Rising prevalence led to an eye examination and its demand for the ophthalmoscopy for diabetes retinopathy, cataract, glaucoma, corneal opacities, and other eye conditions.

SEGMENTATION ANALYSIS

• The Ophthalmoscopes market is segmented into direct & indirect ophthalmoscopes. Welch Allyn, Nidek Inc, Heine USA Ltd., US ophthalmic, Honsun Group, Iridex Corporation, Oscar Boscarlol S.r.l., Zumax Medical Co. Ltd, Rudolf Riester GmbH, Dino-Lite Europe, Medline Industries Inc. are some of the biggest direct ophthalmoscope manufacturing businesses.
• In 2021, direct Ophthalmoscopes accounted for 60.16% of the industry share and stood in prime position.
• Nidek Co. Inc, Ellex Medical Laser Ltd, Carls Zeiss, Ziemer Ophthalmic System Ag, Keeler Ltd, Heine Optotechnik GmbH, Topcon Medical Laser System, Iridex Corporation, Lumenis Ltd, and others are among the leading manufacturers of indirect ophthalmoscopes.
• The wide presence of players with a broad range of product portfolios gives a dynamic nature to the industry. A high number of market players and their global distribution channels increased the market growth.
• The indication market is segmented into glaucoma, diabetic retinopathy, retinal detachment, age-related macular degeneration, cataracts, macular pucker, corneal opacities, trachoetc ma, presbyopia, myopia, astigmatism, peripheral neovascularization, lattice degeneration, etc.) eye diseases. The glaucoma segment accounted for 31.81% market share in 2021 and dominated the other indications. Diabetic retinopathy accounted for 23.37% of market share, age-related macular degeneration segmented accounted for 18.03% market share, and retinal detachment accounted for 5.27% of industry share in 2021.
• End-user is segmented into eye clinics and Hospitals, ophthalmologists & optometrists, and ambulatory surgical centers. The wise presence of eye clinics and hospitals drives the high application rate of ophthalmoscopes for eye testing. In 2021, the eye clinics and hospitals segment accounted for 52.34% market share and dominated the other end-user segment. On the other side, ophthalmologists, optometrist segments, and ambulatory surgical centers accounted for 32.80% and 14.86% industry share. Ambulatory surgical centers are the most widely accepted eye care service, which consistently influenced the industry's growth.

Segmentation by Type

• Direct
• Indirect

Segmentation by Indication

• Glaucoma
• Diabetic Retinopathy
• Age-Related Macular Degeneration
• Retinal Detachment
• Other

Segmentation by End-User

• Eye Clinics & Hospitals
• Ophthalmologist & Optometrist
• Ambulatory Surgical Centres

GEOGRAPHICAL ANALYSIS

• Eye care services are widely available in North America. The high prevalence of eye conditions, greater access to an eye examination, and high awareness drive the high application rate of ophthalmoscope medical devices. Also, the presence of ophthalmoscope market players significantly improved the growth in North America, with a 38.82% share in 2021.
• Europe region stands in the second position with 32.89% market share. In 2021, Europe accounted for around USD 17.44 million and was expected to reach USD 24.34 million by 2027, growing at a CAGR of 5.71% during the forecast period. The increasing frequency of diabetic retinopathy, glaucoma, and cataracts prompted a high rate of ophthalmoscope use in eye care services, which fueled the market growth.
• APAC region is home to diabetes conditions that drive the Ophthalmoscope to identify diabetic retinopathy. On the other side, a dense population and an aging population positively drive market growth in the region, accounting for 20.23% market share.
• Latin America is an emerging market with increasing eye care expenditure, a rising patient population, and growing demand for eye care services. In 2021, Latin America accounted for 5.04% market share 2021.
• Middle East & Africa is one of the major regions with significant growth opportunities for market growth. A high number of glaucoma, diabetic retinopathy, and blindness patients population and increasing government initiatives are the most common factors triggering the market growth in the region. In 2021, Middle East & Africa accounted for a 3.01% market share in the global ophthalmoscope market.

Segmentation by Geography

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
• APAC
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Turkey
  • South Africa
  • Saudi Arabia

KEY QUESTIONS ANSWERED

• 1. How Big is the Ophthalmoscopes Market?
• 2. What are the Latest Trends in The Ophthalmoscopes Market?
• 3. Who are the Key Players in The Ophthalmoscopes Market?
• 4. What are the Growth Enablers in The Ophthalmoscopes Market?
• 5. Which End-User Segment to Hold the Largest Share In The Ophthalmoscope Market By 2027?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

• 4.1 MARKET DEFINITION
  • 4.1.1 INCLUSIONS
  • 4.1.2 EXCLUSIONS
  • 4.1.3 MARKET ESTIMATION CAVEATS
• 4.2 BASE YEAR
• 4.3 SCOPE OF THE STUDY
  • 4.3.1 MARKET SEGMENTATION BY TYPE
  • 4.3.2 MARKET SEGMENTATION BY INDICATION
  • 4.3.3 MARKET SEGMENTATION BY END-USER
  • 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

• 5.1 KEY CAVEATS
• 5.2 CURRENCY CONVERSION
• 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

• 7.1 OVERVIEW

8 MARKET OPPORTUNITIES & TRENDS

• 8.1 TECHNOLOGICAL ADVANCES & NEW APPLICATIONS OF OPHTHALMOSCOPES
• 8.2 GOVERNMENT'S EYE CARE INITIATIVES
• 8.3 HIGHER GROWTH OPPORTUNITIES IN EMERGING MARKETS

9 MARKET GROWTH ENABLERS

• 9.1 RISE IN AWARENESS OF EYE CARE SERVICES IN DEVELOPED COUNTRIES
• 9.2 RISE IN EYE DISORDER PREVALENCE & SURGICAL PROCEDURES
• 9.3 ADVENT OF ADVANCED OPHTHALMOSCOPES
• 9.4 INCREASE IN PATIENT POPULATION WITH EYE DISORDERS

10 MARKET RESTRAINTS

• 10.1 LACK OF EYE CARE SERVICES IN EMERGING MARKETS
• 10.2 INSUFFICIENT OPHTHALMOLOGISTS IN DEVELOPING COUNTRIES
• 10.3 STRINGENT REGULATIONS & PRODUCT RECALLS

11 MARKET LANDSCAPE

• 11.1 MARKET OVERVIEW
• 11.2 MARKET SIZE & FORECAST
  • 11.2.1 INSIGHTS BY GEOGRAPHY
  • 11.2.2 INSIGHTS BY TYPE
  • 11.2.3 INSIGHTS BY INDICATION
  • 11.2.4 INSIGHTS BY END-USER
• 11.3 FIVE FORCES ANALYSIS
  • 11.3.1 THREAT OF NEW ENTRANTS
  • 11.3.2 BARGAINING POWER OF SUPPLIERS
  • 11.3.3 BARGAINING POWER OF BUYERS
  • 11.3.4 THREAT OF SUBSTITUTES
  • 11.3.5 COMPETITIVE RIVALRY

12 TYPE

• 12.1 MARKET SNAPSHOT & GROWTH ENGINE
• 12.2 MARKET OVERVIEW
• 12.3 DIRECT OPHTHALMOSCOPE
  • 12.3.1 MARKET OVERVIEW
  • 12.3.2 MARKET SIZE & FORECAST
  • 12.3.3 MARKET BY GEOGRAPHY
• 12.4 INDIRECT OPHTHALMOSCOPE
  • 12.4.1 MARKET OVERVIEW
  • 12.4.2 MARKET SIZE & FORECAST
  • 12.4.3 MARKET BY GEOGRAPHY

13 INDICATION

• 13.1 MARKET SNAPSHOT & GROWTH ENGINE
• 13.2 MARKET OVERVIEW
• 13.3 GLAUCOMA
  • 13.3.1 MARKET OVERVIEW
  • 13.3.2 MARKET SIZE & FORECAST
  • 13.3.3 MARKET BY GEOGRAPHY
• 13.4 DIABETIC RETINOPATHY
  • 13.4.1 MARKET OVERVIEW
  • 13.4.2 MARKET SIZE & FORECAST
  • 13.4.3 MARKET BY GEOGRAPHY
• 13.5 AGE-RELATED MACULAR DEGENERATION
  • 13.5.1 MARKET OVERVIEW
  • 13.5.2 MARKET SIZE & FORECAST
  • 13.5.3 MARKET BY GEOGRAPHY
• 13.6 RETINAL DETACHMENT
  • 13.6.1 MARKET OVERVIEW
  • 13.6.2 MARKET SIZE & FORECAST
  • 13.6.3 MARKET BY GEOGRAPHY
• 13.7 OTHERS
  • 13.7.1 MARKET OVERVIEW
  • 13.7.2 MARKET SIZE & FORECAST
  • 13.7.3 MARKET BY GEOGRAPHY

14 END-USER

• 14.1 MARKET SNAPSHOT & GROWTH ENGINE
• 14.2 MARKET OVERVIEW
• 14.3 EYE CLINICS & HOSPITALS
  • 14.3.1 MARKET OVERVIEW
  • 14.3.2 MARKET SIZE & FORECAST
  • 14.3.3 MARKET BY GEOGRAPHY
• 14.4 OPHTHALMOLOGISTS AND OPTOMETRISTS
  • 14.4.1 MARKET OVERVIEW
  • 14.4.2 MARKET SIZE & FORECAST
  • 14.4.3 MARKET BY GEOGRAPHY
• 14.5 AMBULATORY SURGICAL CENTERS
  • 14.5.1 MARKET OVERVIEW
  • 14.5.2 MARKET SIZE & FORECAST
  • 14.5.3 MARKET BY GEOGRAPHY

15 GEOGRAPHY

• 15.1 MARKET SNAPSHOT & GROWTH ENGINE
• 15.2 GEOGRAPHIC OVERVIEW

16 NORTH AMERICA

• 16.1 MARKET OVERVIEW
• 16.2 MARKET SIZE & FORECAST
• 16.3 TYPE
  • 16.3.1 MARKET SIZE & FORECAST
• 16.4 INDICATION
  • 16.4.1 MARKET SIZE & FORECAST
• 16.5 END-USER
  • 16.5.1 MARKET SIZE & FORECAST
• 16.6 KEY COUNTRIES
  • 16.6.1 US: MARKET SIZE & FORECAST
  • 16.6.2 CANADA: MARKET SIZE & FORECAST

17 EUROPE

• 17.1 MARKET OVERVIEW
• 17.2 MARKET SIZE & FORECAST
• 17.3 TYPE
  • 17.3.1 MARKET SIZE & FORECAST
• 17.4 INDICATION
  • 17.4.1 MARKET SIZE & FORECAST
• 17.5 END-USER
  • 17.5.1 MARKET SIZE & FORECAST
• 17.6 KEY COUNTRIES
  • 17.6.1 GERMANY: MARKET SIZE & FORECAST
  • 17.6.2 FRANCE: MARKET SIZE & FORECAST
  • 17.6.3 UK: MARKET SIZE & FORECAST
  • 17.6.4 ITALY: MARKET SIZE & FORECAST
  • 17.6.5 SPAIN: MARKET SIZE & FORECAST

18 APAC

• 18.1 MARKET OVERVIEW
• 18.2 MARKET SIZE & FORECAST
• 18.3 TYPE
  • 18.3.1 MARKET SIZE & FORECAST
• 18.4 INDICATION
  • 18.4.1 MARKET SIZE & FORECAST
• 18.5 END-USER
  • 18.5.1 MARKET SIZE & FORECAST
• 18.6 KEY COUNTRIES
  • 18.6.1 JAPAN: MARKET SIZE & FORECAST
  • 18.6.2 CHINA: MARKET SIZE & FORECAST
  • 18.6.3 INDIA: MARKET SIZE & FORECAST
  • 18.6.4 AUSTRALIA: MARKET SIZE & FORECAST
  • 18.6.5 SOUTH KOREA: MARKET SIZE & FORECAST

19 LATIN AMERICA

• 19.1 MARKET OVERVIEW
• 19.2 MARKET SIZE & FORECAST
• 19.3 TYPE
  • 19.3.1 MARKET SIZE & FORECAST
• 19.4 INDICATION
  • 19.4.1 MARKET SIZE & FORECAST
• 19.5 END-USER
  • 19.5.1 MARKET SIZE & FORECAST
• 19.6 KEY COUNTRIES
  • 19.6.1 BRAZIL: MARKET SIZE & FORECAST
  • 19.6.2 MEXICO: MARKET SIZE & FORECAST
  • 19.6.3 ARGENTINA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

• 20.1 MARKET OVERVIEW
• 20.2 MARKET SIZE & FORECAST
• 20.3 TYPE
  • 20.3.1 MARKET SIZE & FORECAST
• 20.4 INDICATION
  • 20.4.1 MARKET SIZE & FORECAST
• 20.5 END-USER
  • 20.5.1 MARKET SIZE & FORECAST
• 20.6 KEY COUNTRIES
  • 20.6.1 TURKEY: MARKET SIZE & FORECAST
  • 20.6.2 SOUTH AFRICA: MARKET SIZE & FORECAST
  • 20.6.3 SAUDI ARABIA: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

• 21.1 COMPETITION OVERVIEW
• 21.2 MARKET SHARE ANALYSIS

22 KEY COMPANY PROFILES

• 22.1 HEINE
  • 22.1.1 BUSINESS OVERVIEW
  • 22.1.2 PRODUCT OFFERINGS
  • 22.1.3 KEY STRATEGIES
  • 22.1.4 KEY STRENGTHS
  • 22.1.5 KEY OPPORTUNITIES
• 22.2 DINO-LITE EUROPE (ANMO ELECTRONICS CORPORATION)
  • 22.2.1 BUSINESS OVERVIEW
  • 22.2.2 PRODUCT OFFERINGS
  • 22.2.3 KEY STRATEGIES
  • 22.2.4 KEY STRENGTHS
  • 22.2.5 KEY OPPORTUNITIES
• 22.3 IRIDEX
  • 22.3.1 BUSINESS OVERVIEW
  • 22.3.2 PRODUCT OFFERINGS
  • 22.3.3 KEY STRATEGIES
  • 22.3.4 KEY STRENGTHS
  • 22.3.5 KEY OPPORTUNITIES
• 22.4 HALMA
  • 22.4.1 BUSINESS OVERVIEW
  • 22.4.2 PRODUCT OFFERINGS
  • 22.4.3 KEY STRATEGIES
  • 22.4.4 KEY STRENGTHS
  • 22.4.5 KEY OPPORTUNITIES
• 22.5 NIDEK
  • 22.5.1 BUSINESS OVERVIEW
  • 22.5.2 PRODUCT OFFERINGS
  • 22.5.3 KEY STRATEGIES
  • 22.5.4 KEY STRENGTHS
  • 22.5.5 KEY OPPORTUNITY
• 22.6 OSCAR BOSCAROL
  • 22.6.1 BUSINESS OVERVIEW
  • 22.6.2 PRODUCT OFFERINGS
  • 22.6.3 KEY STRATEGIES
  • 22.6.4 KEY STRATEGIES
  • 22.6.5 KEY OPPORTUNITIES
• 22.7 RUDOLF RIESTER
  • 22.7.1 BUSINESS OVERVIEW
  • 22.7.2 PRODUCT OFFERINGS
  • 22.7.3 KEY STRATEGIES
  • 22.7.4 KEY STRENGTHS
  • 22.7.5 KEY OPPORTUNITIES
• 22.8 WELCH ALLYN (HILL ROM)
  • 22.8.1 BUSINESS OVERVIEW
  • 22.8.2 PRODUCT OFFERINGS
  • 22.8.3 KEY STRATEGIES
  • 22.8.4 KEY STRENGTHS
  • 22.8.5 KEY OPPORTUNITIES

23 OTHER PROMINENT VENDORS

• 23.1 ALBERT WAESCHLE
  • 23.1.1 BUSINESS OVERVIEW
  • 23.1.2 PRODUCT OFFERINGS
• 23.2 AMERICAN DIAGNOSTIC CORPORATION
  • 23.2.1 BUSINESS OVERVIEW
  • 23.2.2 PRODUCT OFFERINGS
• 23.3 SHANGHAI BOLAN OPTICAL ELECTRIC
  • 23.3.1 BUSINESS OVERVIEW
  • 23.3.2 PRODUCT OFFERINGS
• 23.4 CARL ZEISS
  • 23.4.1 BUSINESS OVERVIEW
  • 23.4.2 PRODUCT OFFERINGS
• 23.5 LUMIBIRD GROUP (ELLEX)
  • 23.5.1 BUSINESS OVERVIEW
  • 23.5.2 PRODUCT OFFERING
• 23.6 ESSILOR INTERNATIONAL (ESSILOR INSTRUMENTS USA)
  • 23.6.1 BUSINESS OVERVIEW
  • 23.6.2 PRODUCT OFFERING
• 23.7 HEIDELBERG ENGINEERING
  • 23.7.1 BUSINESS OVERVIEW
  • 23.7.2 PRODUCT OFFERINGS
• 23.8 INVOTECH EXCEL
  • 23.8.1 BUSINESS OVERVIEW
  • 23.8.2 PRODUCT OFFERINGS
• 23.9 MEDLINE INDUSTRIES
  • 23.9.1 BUSINESS OVERVIEW
  • 23.9.2 PRODUCT OFFERINGS
• 23.10 NEITZ INSTRUMENTS
  • 23.10.1 BUSINESS OVERVIEW
  • 23.10.2 PRODUCT OFFERINGS
• 23.11 SUZHOU KANGJIE MEDICAL
  • 23.11.1 BUSINESS OVERVIEW
  • 23.11.2 PRODUCT OFFERINGS
• 23.12 SPENGLER HOLTEX GROUP
  • 23.12.1 BUSINESS OVERVIEW
  • 23.12.2 PRODUCT OFFERINGS
• 23.13 TOPCON
  • 23.13.1 BUSINESS OVERVIEW
  • 23.13.2 PRODUCT OFFERINGS
• 23.14 LUMENIS
  • 23.14.1 BUSINESS OVERVIEW
  • 23.14.2 PRODUCT OFFERINGS
• 23.15 ZUMAX MEDICAL CO. LTD
  • 23.15.1 BUSINESS OVERVIEW
  • 23.15.2 PRODUCT OFFERINGS
• 23.16 66 VISION TECH
  • 23.16.1 BUSINESS OVERVIEW
  • 23.16.2 PRODUCT OFFERINGS
• 23.17 ZHEJIANG HONSUN MEDICAL TECHNOLOGIES CO. LTD
  • 23.17.1 BUSINESS OVERVIEW
  • 23.17.2 PRODUCT OFFERINGS

24 REPORT SUMMARY

• 24.1 KEY TAKEAWAYS
• 24.2 STRATEGIC RECOMMENDATIONS

25 QUANTITATIVE SUMMARY

• 25.1 GEOGRAPHY
• 25.2 TYPE
• 25.3 INDICATION
• 25.4 END-USER
• 25.5 TYPE (GEOGRAPHICAL DISTRIBUTION)
  • 25.5.1 DIRECT OPHTHALMOSCOPE: MARKET BY GEOGRAPHY
  • 25.5.2 INDIRECT OPHTHALMOSCOPE: MARKET BY GEOGRAPHY
• 25.6 INDICATION (GEOGRAPHICAL DISTRIBUTION)
  • 25.6.1 GLAUCOMA: MARKET BY GEOGRAPHY
  • 25.6.2 DIABETIC RETINOPATHY: MARKET BY GEOGRAPHY
  • 25.6.3 AGE-RELATED MACULAR DEGENERATION: MARKET BY GEOGRAPHY
  • 25.6.4 RETINAL DETACHMENT: MARKET BY GEOGRAPHY
  • 25.6.5 OTHERS: MARKET BY GEOGRAPHY
• 25.7 END-USER (GEOGRAPHICAL DISTRIBUTION)
  • 25.7.1 EYE CLINICS & HOSPITALS: MARKET BY GEOGRAPHY
  • 25.7.2 OPHTHALMOLOGISTS & OPTOMETRISTS: MARKET BY GEOGRAPHY
  • 25.7.3 AMBULATORY SURGICAL CENTERS: MARKET BY GEOGRAPHY

26 APPENDIX

• 26.1 ABBREVIATIONS